Presentation: Clofazimine - repurpose & strategy, January 29

Roxana Drake, MD, PhD from Novartis will give a presentation on January 29, 2016 from 09:00 to 10:00 EST (15:00-16:00 CET) entitled Clofazimine – repurpose & strategy.

The presentation will focus on the current status of clofazimine and on its development as a multidrug-resistant TB drug. The study design and rationale for clofazimine dose selection will be presented.

Click here for instructions on how to connect.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Novartis

Published: Jan. 27, 2016, 8:50 a.m.

Last updated: Jan. 27, 2016, 10 a.m.

Print Share